Takaba, Rika
Ibi, Daisuke
Yoshida, Keisuke
Hosomi, Eri
Kawase, Ririna
Kitagawa, Hiroko
Goto, Hirotaka
Achiwa, Mizuki
Mizutani, Kento
Maeda, Kyosuke
González-Maeso, Javier
Kitagaki, Shinji
Hiramatsu, Masayuki
Funding for this research was provided by:
Nagai Memorial Research Scholarship (223903)
Uehara Memorial Foundation
SENSHIN Medical Research Foundation
TOYOAKI Scholarship Foundation
YOKOYAMA Foundation for Clinical Pharmacology (YRY-1909)
Pharmacological Research Foundation
NOVARTIS Foundation (Japan) for the Promotion of Science
Takeda Science Foundation
Smoking Research Foundation
Brain Science Foundation
Research Center for Pathogenesis of Intractable Disease from the Research Institute of Meijo University
Japan Society for the Promotion of Science (15H06719, 16K19786, 19K07332, and 22K06872)
NIH grant (R01MH084894)
Article History
Received: 4 July 2023
Accepted: 7 October 2023
First Online: 24 October 2023
Change Date: 12 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00210-024-02997-w
Declarations
:
: All experiments followed the guidelines established by the Japanese Pharmacological Society and Institute for Experimental Animals at Meijo University. Protocols were approved by the Animal Ethics Board of Meijo University [permit no. (2017–2023)-11].
: The authors declare no competing interests.